Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1
卡美司群联合三种全球获批的 CDK4/6 抑制剂治疗 ER+、HER2- 晚期乳腺癌女性患者:SERENA-1 研究结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1198
Baird, Richard D; Bermejo de Las Heras, Begoña; Ruiz-Borrego, Manuel; Vaklavas, Christos; Moreno, Irene; Oliveira, Mafalda; Armstrong, Anne; Turner, Nicholas; Incorvati, Jason; Twelves, Chris; Ciruelos, Eva; Hamilton, Erika; Patel, Manish R; Kabos, Peter; Ciardullo, Carmela; Klinowska, Teresa; Lindemann, Justin P O; Mathewson, Alastair M; Morrow, Christopher J; Sykes, Andy; Yang, Jincheng; Zhang, Bairu; Victoria, Ivan